THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER
Ovarian suppression (OS) is an effective method of treating hormone sensitive breast cancer. The combination of OS and tamoxifen in breast cancer is more effective than any of these methods used as monotherapy. A number of clinical trials confirmed the need for OS chemotherapy in patients with hormo...
Saved in:
Main Authors: | I. A. Koroleva (Author), M. V. Kopp (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovarian function suppression: To what extent is it necessary for premenopausal patients with operable hormone-sensitive breast cancer?
by: P. V. Koposov
Published: (2015) -
MODERN VIEWS ON THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER: SABCS-2017 NEWS
by: A. A. Bozhok
Published: (2018) -
Individual approach to choosing an appropriate regimen of adjuvant hormone therapy in patients with early-stage breast cancer
by: E. M. Slonimskaya, et al.
Published: (2018) -
Preliminary results of accelerated partial breast irradiation in the combination organ-saving treatment of patients with early-stage breast cancer
by: O. P. Trofimova, et al.
Published: (2014) -
Cancer-associated thrombosis during chemotherapy: treatment and prevention: A review
by: Irina A. Koroleva, et al.
Published: (2022)